Search

everythinglearnresearchcommunity

for

Search:↓

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

MicroRNA-302 helps improve the conversion of body cells into stem cells by blocking NR2F2.

Targeting regulatory T cells may help treat age-related diseases.

Fucoidan reduces bone cell formation by affecting T-cell activity.

Increased regulatory T cell activity may lead to better outcomes in acute diffuse and total alopecia.

Key genes linked to immune response are upregulated in hair follicles and skin tissues in chronic discoid lupus erythematosus.

Key genes linked to immune response are highly active in lupus-affected hair follicles.

CD44 variant changes start alopecia areata, but don't maintain it.

Folliculotropic mycosis fungoides can occur in children and is diagnosed with specific tests, but often stays in early stages with treatment.

The patient with both scarring and non-scarring hair loss showed complex immune reactions and improved with steroid treatment.

Repeated biopsies are crucial for managing lupus panniculitis when initial treatments fail.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Hair growth phase and certain genes can speed up wound healing, while an inflammatory mediator can slow down new hair growth after a wound. Understanding these factors can improve tissue regeneration during wound healing.

New hair can grow from large wounds in mice, but less so as they age, involving reprogramming of skin cells and specific molecular pathways.

Regulatory T cells and mesenchymal stem cells work together to prevent immune system overreactions and tissue damage.

The calcineurin/NFAT pathway plays a significant role in the development and growth of a type of skin cancer called cutaneous squamous cell carcinoma.

B-Raf and C-Raf are essential for maintaining melanocyte stem cells to prevent hair graying.

Most HIV patients develop skin symptoms that can indicate the stage of their disease.

Mutations in Gasdermin A3 cause skin inflammation and hair loss by disrupting mitochondria.

Centipeda minima extract helps hair grow by activating important growth signals and could be a promising hair loss treatment.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

c-Myc activation in mouse skin increases sebaceous gland growth and affects hair follicle development.

Researchers found a new genetic mutation causing a rare hair loss condition in the first Japanese child studied.

Higher dihydrotestosterone may be linked to more inflammation in COVID-19 patients with low testosterone.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Malt1 protease is essential for regulatory T cell function and could be targeted to boost antitumor immunity.

Potential therapeutic targets for scarring hair loss are identified.

Immune cells are crucial for hair growth and preventing hair loss.

Amotosalen-treated donor T-cells can prevent late CMV infection after bone marrow transplants.

Regulatory T cells protect hair follicle stem cells by maintaining immune privilege in the skin.